Artificial Cornea, Inc., through its application of protocols developed at the Tissue Bioengineering Lab of Simon Bolivar University, may offer new hope for millions of people the world over who suffer from blindness caused by disease or injury to the cornea. Artificial Cornea, Inc. is responsible for the manufacture of the artificial cornea, the lens which focuses light on the retina and creates the image in the eye. Composed of a hydro gel or polymer that can store a large amount of water in its structure, it functions as a replacement for the damaged tissue. Regenerative medicine is a field with the potential for exponential growth. As it grows in importance it will attract capital investments worth millions of dollars, world-wide. The Tissue Bioengineering Lab of Simon Bolivar University has significant experience in generating replacement corneal tissue. Through this connection, Artificial Cornea, Inc. is a leading developer of this important medical material.